Close
Smartlab Europe
Inizio Ignite

Press Releases

Enzolytics and Samsung Biologics Announce Development and Manufacturing Agreement for Anti-HIV and Anti-SARS-CoV-2 Monoclonal Antibody Therapies

Samsung Biologics , a leading contract development and manufacturing organization and Enzolytics (ENZC), a drug development company committed to commercializing multiple proprietary therapeutics to treat debilitating infectious diseases, announced the signing of a strategic CDMO partnership agreement. Under the terms...

Syntegon and Vetter win PDA Drug Delivery Innovation Award for Versynta microBatch

Together with Vetter, an international pharmaceutical service provider for injectables, Syntegon (formerly Bosch Packaging Technology) has won the PDA Drug Delivery Innovation Award. In the "Partnership Innovation" category, the Parental Drug Association (PDA) honors development projects by pharmaceutical and...

CTI BioPharma Announces Topline Data from Final Analysis of the PRE-VENT Clinical Trial Evaluating Pacritinib as a Treatment for Severe COVID-19

CTI BioPharma Corp announced topline results from the PRE-VENT trial (NCT04404361) of pacritinib in hospitalized patients with severe COVID-19. PRE-VENT, a randomized, double-blind, placebo-controlled multicenter study, compared pacritinib/standard of care versus placebo/standard of care in hospitalized patients with severe...

Moderna Announces European Medicines Agency Authorizes Third Dose of COVID-19 Vaccine for Immunocompromised Individuals Aged 12 Years and Older

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines announced that the European Medicines Agency (EMA) has authorized a third dose of the Moderna COVID-19 vaccine (Spikevax) given at least 28 days after the second dose...

TriLink BioTechnologies Extends EyeGene Partnership for COVID-19 Vaccine Development in South Korea

TriLink BioTechnologies, a Maravai LifeSciences company and a leader in the production of nucleic acids for research, diagnostics and therapeutics applications, announced that it expects to supply its proprietary CleanCap® mRNA capping technology and the modified nucleoside, uridine triphosphate,...

Clarity and Evergreen enter Targeted Copper Theranostics manufacturing agreement for US clinical trials

Clarity Pharmaceuticals, an Australian-based clinical stage radiopharmaceutical company developing next-generation products to address the growing need in oncology, and Evergreen Theragnostics, Inc., a radiopharmaceutical contract manufacturer, are pleased to announce that the companies have entered into a Targeted Copper...

MedicalTech Innovation Forum to address integral challenges faced by the Indian medical devices industry

Jointly organised by Messe Frankfurt India and Andhra Pradesh MedTech Zone (AMTZ), the first-ever physical edition of MedicalTech Innovation Forum at Visakhapatnam will bring leaders from medical technology industry to discuss opportunties, encourage indigenous manufacturing and innovation of medical...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »